Search

everythinglearnresearchcommunity

for

Search:↓

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Weight loss improves PCOS symptoms and overall health.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Women with PCOS have a higher risk of heart disease.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.